Skip to content

An open labelled double arm non randomized phase II clinical trail To evaluate the efficacy of Siddhar yoga Maruthuva muraigal and siddha medicine MOOKIRATTAI CHOORANAM (internal medicine) in the management of LUMBAR SPONDYLOSIS

"AN OPEN LABELLED DOUBLE ARM NON RANDOMIZED PHASE II, CLINICAL TRAIL TO EVALUATE THE EFFICACY OF SIDDHAR YOGA MARUTHUVA MURAIGAL AND SIDDHA MEDICINE "MOOKIRATTAI CHOORANAM" IN THE MANAGEMENT OF "THANDAGA VATHAM"(LUMBAR SPONDYLOSIS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042547
Enrollment
40
Registered
2022-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: MOOKIRATTAI CHOORANAM ( internal medicine): 1 to 3 gram twice a day for 48 days Control Intervention1: Siddhar yoga Maruthuva muraigal with MOOKIRATTAI CHOORANAM (internal medicine): Yo

Sponsors

Dr DIVYABHARATHI S P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age - 30 to 60 years 2. Sex - both male and female 3. Patient having symptoms of pain in lumbar region, radiating pain to buttocks and Lower limbs, stiffness present in lumbar region, exacerbation of pain on movements, tingling sensation present. 4. patient who are willing to give radiological investigation and provide blood for lab investigation. 5. Patient willing to sign the informed consent stating that he/she conscientiously strict to the treatment during 48 days.

Exclusion criteria

Exclusion criteria: 1. Cardiac disease 2. Autoimmune disease like RA, SLE, Psoriasis. 3. Pregnancy women and lactating mothers 4. Osteomyelitis 5. Dislocation and tuberculosis of spine 6. Patient with any other serious illness and other systemic illness.

Design outcomes

Primary

MeasureTime frame
Decreases the intensity of painTimepoint: Decreases the intensity of pain within 8 weeks

Secondary

MeasureTime frame
NILTimepoint: Nil

Countries

India

Contacts

Public ContactDr A S POONGODI KANTHIMATHI MDS

Government Siddha medical college and hospital, palayamkottai

arunapriya1995@gmail.com9865105356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026